[182 Pages Report] A gastrointestinal stent is a cylindrical medical device primarily used as a safe and effective alternative to surgery or repetitive endoscopic procedures to widen a narrow or stenosed lumen in order maintain the patency of the lumen. The gastrointestinal stent market is expected to reach USD 452.6 Million by 2022 from USD 337.5 Million in 2016, at a CAGR of 5.1% during the forecast period. The increasing preference for minimally invasive surgeries and rising prevalence of GI cancers and other digestive diseases are the major factors driving the growth of the global market.

Objectives of the Study

To define, describe, and forecast the global gastrointestinal stent market on the basis of product, material, disease type, end user, and region

To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)

To analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market

To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

To forecast the size of the global market with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

To profile the key players in the global market and comprehensively analyze their core competencies

To track and analyze competitive developments such as R&D; activities; mergers and acquisitions; and product developments of the leading players in the global gastrointestinal stent market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global gastrointestinal stent industry and estimate the size of other dependent submarkets. Various secondary sources such as directories, industry journals, databases (such as Hoover�s, Bloomberg Business, Factiva, and Avention), and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

To know about the assumptions considered for the study, download the pdf brochure

Boston Scientific (US), Cook Group (US), ELLA-CS (Czech Republic), Merit Medical Systems (US), Taewoong Medical (South Korea), Micro-Tech (China), and M.I. Tech (South Korea) are some of the key players in the global gastrointestinal stent market.

Target Audience

Manufacturers & distributors of gastrointestinal stents

Healthcare institutions (hospitals and ambulatory surgery centers)

Contract manufacturing organizations

Research institutes

Government associations

Market research and consulting firms

Venture capitalists and investors

Scope of the Report

In this report, the global market has been segmented into the following segments and subsegments:

Gastrointestinal Stent Market, by Product

Biliary Stents

Duodenal Stents

Colonic Stents

Pancreatic Stents

Esophageal Stents

Gastrointestinal Stent Market, by Material

Self-expanding Metal Stents Stainless Steel Stents Nitinol Stents Other Metal Stents

Plastic Stents

Gastrointestinal Stent Market, by Disease Type

Biliary Diseases

Inflammatory Bowel Diseases

Gastrointestinal Cancers Colorectal Cancer Stomach Cancer Pancreatic Cancer Esophageal Cancer



Gastrointestinal Stent Market, by End User

Hospitals

Ambulatory Surgery Centers (ASCs)

Gastrointestinal Stent Market, by Region

North America US Canada

Europe Germany France UK Italy Spain Rest of Europe

Asia Pacific China Japan India Rest of Asia Pacific

Latin America

The Middle East and Africa

Available Customization:

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs. The following customization options are available for the report:

Geographic Analysis

Further breakdown of the Rest of Asia Pacific gastrointestinal stent market into South Korea, Australia, New Zealand, and others.

Further breakdown of the Rest of Europe gastrointestinal stent market into Belgium, Russia, the Netherlands, Switzerland, and others.

Company Information

Detailed analysis and profiling of additional market players (up to 5)

The global gastrointestinal stent market is projected to reach USD 452.6 Million by 2022 from USD 353.4 Million in 2017, at a CAGR of 5.1% during the forecast period. Market growth can be attributed to the growth in the geriatric population, increasing preference for minimally invasive surgeries, rising prevalence of GI cancers and other digestive diseases, and changing lifestyles.

The report analyzes the global gastrointestinal stent market, by product, material, disease type, end user, and region. Based on product, the biliary stents segment accounted for the largest share of global market in 2016. This can be attributed to the high prevalence of pancreatic cancer and biliary diseases as well as the growth in the number of surgical procedures for the treatment of these diseases.

Based on material, the self-expanding metal stents segment accounted for the largest share of the global gastrointestinal stent market in 2016. The large share of this segment can be attributed to their ease of insertion, a lower possibility of dislodgment or migration, its longer patency because of the large luminal diameters, high longevity, and large use of it in interventional endoscopy for various malignant obstructions.

On the basis of disease type, the biliary diseases segment accounted for the largest share of the global gastrointestinal stent market in 2016. The large share of this segment is attributed to the high prevalence of gastrointestinal diseases in the elderly population.

The global gastrointestinal stent market, by end user, is segmented into hospitals and ambulatory surgery centers. In 2016, the hospitals segment accounted for the largest share of the market. The large share of this segment can be attributed to the large number of endoscopic procedures performed in hospitals for various gastrointestinal diseases.

Geographically, the global gastrointestinal stent market has been segmented into five major regional segments North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2016, North America accounted for the largest share of the global market in 2016, followed by Europe and Asia Pacific. The highly developed healthcare system, rising geriatric population, growing adoption of technologically advanced stents, and the presence of key players are the major factors responsible for the large share of North America in the global market.

The major complications associated with the implementation of gastrointestinal stents include stent misplacement or displacement, bleeding, obstruction, perforation, stent fracture or collapse, and infection. Bacterial colonization is a major factor leading to plastic stent occlusion, which results in sludge formation and luminal obstruction. Covered gastrointestinal stents generally prevent obstruction from tumor ingrowth with a covering membrane but have a higher migration rate. These complications associated with gastrointestinal stenting are limiting their adoption.

The prominent players in the global gastrointestinal stent market are Boston Scientific (US), Cook Group (US), C.R. Bard (US), ELLA-CS (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED (US), Cantel Medical (US), Olympus (Japan), Taewoong Medical (South Korea), Micro-Tech (China), Endo-Flex (Germany), M.I. Tech (South Korea), and Diagmed Healthcare (UK).

Boston Scientific Corporation (US) dominated the global gastrointestinal stent market in 2016. The company focuses on increasing its share in the market by strategically investing in R&D; activities. For instance, in 2016, the company invested USD 920 million in R&D;, as compared to USD 876 million in 2015. The company�s focus on improving its speed and performance through new capabilities, processes, and advanced innovative technologies; its expanding commercial presence globally; and its cost-reduction initiatives help it to accelerate its growth in the market. In 2016, the company�s revenue reported a growth of 12% as compared to the previous year. The company is also focusing on expanding its business in emerging countries. It reported a growth of 22% in its annual revenue in China, which is one of the largest emerging markets in the developing world.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst